Palvella Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.15 M | $143.78 M | 29.26% | 8.82% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2026 | 980.76 K | $122.25 M | 38.30% | 7.50% |
| BVF INC/IL | 05/15/2026 | 960.99 K | $119.79 M | 9.33% | 7.34% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 882.40 K | $109.99 M | 22.15% | 6.74% |
| BLACKROCK, INC. | 05/13/2026 | 686.85 K | $85.62 M | 22.86% | 5.25% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 640.61 K | $79.85 M | 65.33% | 4.90% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 477.29 K | $59.49 M | 100.00% | 3.65% |
| STATE STREET CORP | 05/15/2026 | 459.00 K | $57.21 M | 9.17% | 3.51% |
| FEDERATED HERMES, INC. | 05/11/2026 | 433.02 K | $53.98 M | 17.66% | 3.31% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 402.56 K | $50.18 M | 9,742.64% | 3.08% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2026 | 374.04 K | $46.62 M | 100.00% | 2.86% |
| WOODLINE PARTNERS LP | 05/15/2026 | 317.52 K | $39.58 M | 5.65% | 2.43% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 262.84 K | $27.51 M | -2.30% | 2.01% |
| SIREN, L.L.C. | 05/14/2026 | 257.49 K | $32.10 M | 243.31% | 1.97% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 233.25 K | $29.05 M | 129.24% | 1.78% |
| FMR LLC | 05/15/2026 | 215.81 K | $26.90 M | -6.88% | 1.65% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 206.40 K | $25.73 M | 0.32% | 1.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 205.61 K | $25.64 M | 14.87% | 1.57% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 195.03 K | $24.31 M | 100.00% | 1.49% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 194.18 K | $24.20 M | 96.27% | 1.48% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 193.80 K | $24.16 M | -8.39% | 1.48% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 179.92 K | $22.43 M | 100.00% | 1.38% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 170.00 K | $21.19 M | 77.08% | 1.30% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 161.50 K | $20.13 M | 100.00% | 1.23% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 148.09 K | $18.46 M | 100.00% | 1.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 141.60 K | $17.65 M | 270.68% | 1.08% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 134.60 K | $16.78 M | 100.00% | 1.03% |
| MORGAN STANLEY | 05/15/2026 | 127.99 K | $15.95 M | -42.00% | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 105.82 K | $13.19 M | 100.00% | 0.81% |
| UBS GROUP AG | 05/05/2026 | 104.54 K | $13.03 M | 186.36% | 0.80% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 96.73 K | $12.06 M | -11.16% | 0.74% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 93.65 K | $11.67 M | 2,590.98% | 0.72% |
| 05/08/2026 | 90.86 K | $11.33 M | 100.00% | 0.69% | |
| CLIO ASSET MANAGEMENT LLC | 04/21/2026 | 90.76 K | $11.31 M | -0.97% | 0.69% |
| APIS CAPITAL ADVISORS, LLC | 05/15/2026 | 89.00 K | $11.09 M | 100.00% | 0.68% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 88.16 K | $10.99 M | 14.05% | 0.67% |
| 05/14/2026 | 82.69 K | $10.31 M | 0.00% | 0.63% | |
| ABRDN PLC | 04/29/2026 | 81.08 K | $10.11 M | 100.00% | 0.62% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 70.00 K | $8.73 M | 262.69% | 0.54% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 69.90 K | $8.71 M | 46.60% | 0.53% |
| AWM INVESTMENT COMPANY, INC. | 05/15/2026 | 69.42 K | $8.65 M | 0.00% | 0.53% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 67.10 K | $8.36 M | -29.59% | 0.51% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 64.78 K | $8.08 M | 100.00% | 0.50% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 64.63 K | $8.06 M | 100.00% | 0.49% |
| NORTHERN TRUST CORP | 05/14/2026 | 64.37 K | $8.02 M | 18.13% | 0.49% |
| SEVEN GRAND MANAGERS, LLC | 05/06/2026 | 60.00 K | $7.48 M | 100.00% | 0.46% |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2026 | 59.41 K | $7.41 M | -2.01% | 0.45% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 50.00 K | $6.23 M | 100.00% | 0.38% |
| NEUBERGER BERMAN GROUP LLC | 05/14/2026 | 49.10 K | $6.12 M | 9.36% | 0.38% |
| INVESCO LTD. | 05/12/2026 | 48.53 K | $6.05 M | -10.59% | 0.37% |
Palvella Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of Palvella Therapeutics Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 960,619
EMERALD ADVISERS, LLC: 229,486
EMERALD MUTUAL FUND ADVISERS TRUST: 129,847
abrdn plc: 120,238
Clio Asset Management LLC: 86,343
FIFTH THIRD BANCORP: 35,585
100.93% of Palvella Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.85 M shares in the last 24 months. This purchase volume represents approximately $1.89 B in transactions.